Croda International Plc (LON:CRDA) insider Steve Foots purchased 2 shares of the firm’s stock in a transaction on Friday, September 10th. The stock was acquired at an average cost of GBX 9,230 ($120.59) per share, for a total transaction of £184.60 ($241.18).
Steve Foots also recently made the following trade(s):
- On Monday, July 12th, Steve Foots bought 2 shares of Croda International stock. The stock was purchased at an average cost of GBX 7,694 ($100.52) per share, for a total transaction of £153.88 ($201.05).
Shares of LON CRDA opened at GBX 9,208 ($120.30) on Wednesday. The company has a quick ratio of 1.12, a current ratio of 1.98 and a debt-to-equity ratio of 58.34. The firm’s 50-day moving average price is GBX 8,625.88 and its two-hundred day moving average price is GBX 7,392.84. Croda International Plc has a 52-week low of GBX 5,843.10 ($76.34) and a 52-week high of GBX 9,358 ($122.26). The stock has a market capitalization of £12.85 billion and a P/E ratio of 50.62.
A number of brokerages have recently commented on CRDA. JPMorgan Chase & Co. raised their target price on shares of Croda International from GBX 5,700 ($74.47) to GBX 6,600 ($86.23) and gave the company an “underweight” rating in a research note on Wednesday, July 28th. HSBC upgraded Croda International to a “buy” rating and raised their target price for the company from GBX 6,100 ($79.70) to GBX 8,600 ($112.36) in a report on Thursday, July 8th. Berenberg Bank lifted their price objective on shares of Croda International from GBX 7,800 ($101.91) to GBX 9,400 ($122.81) and gave the company a “buy” rating in a research note on Tuesday, July 27th. Deutsche Bank Aktiengesellschaft upped their target price on shares of Croda International from GBX 7,600 ($99.29) to GBX 8,500 ($111.05) and gave the company a “hold” rating in a research note on Thursday, August 5th. Finally, Barclays raised shares of Croda International to an “equal weight” rating and lifted their price target for the stock from GBX 6,000 ($78.39) to GBX 8,400 ($109.75) in a research note on Friday, July 30th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of GBX 8,450 ($110.40).
About Croda International
Croda International Plc creates, makes, and sells specialty chemicals in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company operates in four segments: Personal Care, Life Sciences, Performance Technologies, and Industrial Chemicals. It offers adhesives; crop protection additives and adjuvants, seed enhancement and animal health chemicals, chemical bio-stimulants, and specialty additives for agricultural films; and lubricant additives, coatings and polymers, vehicle cleaning chemicals, and products for automotive textiles and fibers, as well as specialty additives for plastics, and battery and catalyst industries.
Featured Article: Learning About the VIX – Volatility Index
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.